CORDIS call2024

HORIZON-JU-GH-EDCTP3-2024-Mpox

HORIZON-JU-GH-EDCTP3-2024-Mpox

Programme
HORIZON
Funded projects (dataset)
9
EU contribution (sum)
€12,103,329
Portal deadline

Leading topic in historical projects: HORIZON-JU-GH-EDCTP3-2024-Mpox

Start here

Suggested partners for this call

Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.

Top coordinators

Organisations that coordinated the most funded projects under this call.

Organisations strong on this topic

Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).

Frequent collaborators

Pairs that often appear together in the same funded project under this call.

Proposal partner finder

One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.

Typical consortium pattern

Derived from historical funded projects linked to this CORDIS call in Grantibase.

Avg. orgs / project
6.11
Median orgs / project
6
Min / max orgs
49

Country presence

Participant rows (an org can appear in multiple countries if data varies).

  • Congo - Kinshasa11
  • Belgium5
  • Uganda5
  • United Kingdom5
  • Tanzania3
  • Spain3
  • France2
  • Rwanda2
  • Canada2
  • Congo - Brazzaville2
  • Italy2
  • Norway1
  • Denmark1
  • Sweden1
  • Burundi1
  • Netherlands1
  • Finland1
  • United States1

Organization types

  • university24 orgs · 31 rows
  • research_institute11 orgs · 15 rows
  • company3 orgs · 4 rows
  • other4 orgs · 4 rows
  • public_body1 orgs · 1 rows

Topics in funded projects

Related funded projects

Largest EU contributions in this call — useful to see who already won funding on similar lines.

Open full project list in advanced search

ProjectEU contribution
PregInPoxVac

MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE

€1,599,328
MOVIE-TRACE

Addressing Critical Gaps in mpox epidemiology in DRC - The MOVIE and TRACE studies

€1,430,875
ODIN-MPox

Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa

€1,378,273
MpoxVax AFRIVAC

Expanding a prospective, clinical trial examining the immune response of participants receiving Modified Vaccinia Ankara vaccine to Africa.

€1,371,784
MPOX-PROBE

Strengthening epidemiological, genomic and community surveillance of Mpox virus (MPXV) at the Congo River border for DRC and RoC

€1,299,994
MBOTE-SK

Tackling and investigating the South-Kivu mpox outbreak

€1,263,076
DECIPHER-MPOX

Deciphering host genetics and viral determinants of MPOX epidemiology in the Democratic Republic of Congo

€1,260,000
JUA KIVU

Joint Understanding and Analysis of clade I monkeypox epidemiology, evolution and immunology in South Kivu

€1,250,000
PREGMPOX

Impact of MPXV infection on pregnancy outcome and newborn health

€1,250,000